Small public and private drug developers are experiencing a wave of aggressive financing, while biotech stocks of all sizes extended their rally into a fourth week.
Marie Daghlain
Advertisement
Articles by Marie Daghlain
Advertisement
Latest Updated Articles
- Upstart Biotechs Rake in the Cash as Sector Rally Continues
September 27th 2010
Advertisement
Advertisement
Trending on Medical Economics
1
Florida's dengue outbreak: What physicians need to know now
2
AI system outperforms physicians on diagnostic accuracy in Microsoft study
3
Pay cuts, payer AI and the staff who keep leaving: What we heard at MGMA's 100th annual conference
4
Your AI scribe is saving you time. Is it also building the case against you?
5